[1]刘潺潺,李婷.抗NMDA受体脑炎的临床分型和调查[J].卒中与神经疾病杂志,2017,24(03):214-216+222.[doi:10.3969/j.issn.1007-0478.2017.03.011]
　Liu Chanchan,Li Ting..Clinical Study of Anti-NMDA Receptor Encephalitis[J].Stroke and Nervous Diseases,2017,24(03):214-216+222.[doi:10.3969/j.issn.1007-0478.2017.03.011]
点击复制

抗NMDA受体脑炎的临床分型和调查()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第24卷
期数:
2017年03期
页码:
214-216+222
栏目:
论 著
出版日期:
2017-06-26

文章信息/Info

Title:
Clinical Study of Anti-NMDA Receptor Encephalitis
文章编号:
1007-0478(2017)03-0214-04
作者:
刘潺潺; 李婷
441021 湖北文理学院附属襄阳市中心医院神经内科北区(刘潺潺),心内科[李婷(通信作者)]
Author(s):
Liu Chanchan;  Li Ting.
Department of Neurology, Xiangyang Central Hospital, Hubei University of Arts and Science, Xiangyang, 441021
关键词:
抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎 预后
Keywords:
Anti-N-methyl-D-aspartate receptor(NMDAR)Encephalitis Prognosis
分类号:
R512.3
DOI:
10.3969/j.issn.1007-0478.2017.03.011
摘要:
目的 了解抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎分型、疗效和预后。方法 2013年1月～2015年8月在武汉同济医院和襄阳市中心医院收集抗NMDAR脑炎确诊患者。抗体检测方法均采用转染细胞免疫荧光法(CBA),将抗NMDAR脑炎分为三种亚型,急性期治疗方案首选采用甲强龙冲击治疗、丙种球蛋白(0.4 g·kg-1·d-1,5 d)、血浆置换治疗,二线治疗方案为环磷酰胺,随访方法为12个月改良Rankin量表。结果 32例患者完成研究,所有患者均没有发现畸胎瘤等肿瘤。32例患者采用甲强龙冲击治疗方案; 对疗效不佳的23例患者又采用丙种球蛋白治疗; 没有患者行血浆转换; 9例患者采用免疫抑制剂治疗方案。12个月时改良Rankin量表(0～2分)转归为24例。结论 采用国外学者提出的诊断标准、临床分型和治疗方案后大部分抗NMDAR脑炎患者取得较好疗效。
Abstract:
ObjectiveTo investigate the anti-N-methyl-D-aspartate receptor(NMDAR)encephalitis receptor type, effect and prognosis.Methods 2013.1-2015.8 Tongji Hospital in Wuhan and Xiangyang central hospital to collect anti-NMDAR encephalitis diagnosed patients. Antibody detection methods are used in the transfected cells by immunofluorescence(CBA), will be divided into three subtypes of anti-NMDAR encephalitis, acute phase treatment of choice for the use of methylprednisolone pulse therapy, gamma globulin, plasma exchange treatment, second-line treatment options for cyclophosphamide, and methods of follow-up was modified Rankin scale of 12 months.Results 32 patients completed the study, all patients were not found teratoma and other tumors. 32 patients using methylprednisolone pulse therapy programs,then poor efficacy of 23 patients using gamma globulin treatment. No patients with plasma exchange, nine patients using immunosuppressive regimens. Outcome of 24 patients were modified Rankin(0-2)Scale after 12 months.Conclusion The use of standards of diagnosis and treatment, the majority of anti-NMDAR encephalitis achieve efficacy, and still need further study.

参考文献/References:

[1] Dalmau J,Gleichman AJ,Hughes EG,et al.Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies[J].The Lancet Neurology,2008,7(12):1091-1098.
[2] Kayser MS,Dalmau J.Anti-NMDA receptor encephalitis, autoimmunity, and psychosis[J].Schizophr Res,2016,176(1):36-40.
[3] Graus F,Titulaer MJ,Balu R,et al.A clinical approach to diagnosis of autoimmune encephalitis[J].Lancet Neurol,2016,15(4):391-404.
[4] Desena AD,Greenberg BM,Graves D.Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis[J].Pediatr Neurol,2014,51(4):542-549.
[5] Kuppuswamy PS,Takala CR,Sola CL.Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions[J].Gen Hosp Psychiatry,2014,36(4):388-391.
[6] Gable MS,Sheriff H,Dalmau J,et al.The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project[J].Clin Infect Dis,2012,54(7):899-904.
[7] Mann AP,Grebenciucova E,Lukas RV.Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges[J].Ther Clin Risk Manag,2014,10(2):517-525.
[8] Dalmau J,Lancaster E,Martinez-Hernandez E,et al.Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis[J].The Lancet Neurology,2011,10(1):63-74.
[9] Schmitt SE,Pargeon K,Frechette ES,et al.Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis[J].Neurology,2012,79(11):1094-1100.
[10] Matsumoto T,Matsumoto K,Kobayashi TA.Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis[J].Psychiatry Clin Neurosci,2012,66(3):242-243.
[11] Titulaer MJ,Mccracken L,Gabilondo I,et al.Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J].The Lancet Neurology,2013,12(2):157-165.
[12] Wandinger KP,Saschenbrecker S,Stoecker W,et al.Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis[J].J Neuroimmunol,2011,231(1/2):86-91.

更新日期/Last Update: 2017-06-20